Speaker: 

Cassandra Lombardo, PharmD, Resident, Geisinger - has nothing to disclose. 

Moderator: 

Tristan Maiers, PharmD, BCOP, Geisinger - has nothing to disclose. 

Learning Objectives: 

At the conclusion of this session, the participant should be able to: 

  • Discuss the incidence of fungal infections in patients with hematologic malignancy
  • Identify infection risk in association with cancer type and regimen used
  • Recognize antifungal agents used and their place in therapy
  • Apply antifungal prophylaxis to a patient case

Disclosure of Relevant Financial Relationships with/without Commercial Interests:

The Planning Committee consisting of Tristan Maiers, PharmD, BCOP, Activity Director, Rajiv Panikkar, MD, Michele Long, MS, BSN, OCN, Jaime Weeder, CRNP, Christopher Kashi, PA-C and Caitlin McDonald, CPht, CVT have no identified disclosures. 

CE Committee Member/Content Reviewers have nothing to disclose. 

Any/All relevant financial relationships have been mitigated. 

Content Disclosure: 

This presentation/content is HIPPA compliant. 

Commerical Support for this Session

None.

Session date: 
02/20/2024 - 7:00am to 8:00am EST
Location: 
Virtual using Microsoft Teams
United States
  • 1.00 ACPE
  • 1.00 ACPE Tech
  • 1.00 AMA PRA Category 1 Credit
  • 1.00 ANCC
  • 1.00 Participation Credit

Please login or register to take this course.